BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 18325827)

  • 1. Is there a serious risk of resistance development to azoles among fungi due to the widespread use and long-term application of azole antifungals in medicine?
    Hof H
    Drug Resist Updat; 2008; 11(1-2):25-31. PubMed ID: 18325827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mechanisms of resistance to antifungal agents].
    Makimura K
    Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():466-70. PubMed ID: 17455664
    [No Abstract]   [Full Text] [Related]  

  • 3. Genesis of Azole Antifungal Resistance from Agriculture to Clinical Settings.
    Azevedo MM; Faria-Ramos I; Cruz LC; Pina-Vaz C; Rodrigues AG
    J Agric Food Chem; 2015 Sep; 63(34):7463-8. PubMed ID: 26289797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of resistance to azole antifungals.
    Marichal P; Vanden Bossche H
    Acta Biochim Pol; 1995; 42(4):509-16. PubMed ID: 8852341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new, broad-spectrum azole antifungal: posaconazole--mechanisms of action and resistance, spectrum of activity.
    Hof H
    Mycoses; 2006; 49 Suppl 1():2-6. PubMed ID: 16961575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting efflux pumps to overcome antifungal drug resistance.
    Holmes AR; Cardno TS; Strouse JJ; Ivnitski-Steele I; Keniya MV; Lackovic K; Monk BC; Sklar LA; Cannon RD
    Future Med Chem; 2016 Aug; 8(12):1485-501. PubMed ID: 27463566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular basis of resistance to azole antifungals.
    Lupetti A; Danesi R; Campa M; Del Tacca M; Kelly S
    Trends Mol Med; 2002 Feb; 8(2):76-81. PubMed ID: 11815273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medically important fungi respond to azole drugs: an update.
    Zavrel M; White TC
    Future Microbiol; 2015; 10(8):1355-73. PubMed ID: 26234644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-based optimization of azole antifungal agents by CoMFA, CoMSIA, and molecular docking.
    Sheng C; Zhang W; Ji H; Zhang M; Song Y; Xu H; Zhu J; Miao Z; Jiang Q; Yao J; Zhou Y; Zhu J; Lü J
    J Med Chem; 2006 Apr; 49(8):2512-25. PubMed ID: 16610794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antifungal drug resistance mechanisms.
    Pemán J; Cantón E; Espinel-Ingroff A
    Expert Rev Anti Infect Ther; 2009 May; 7(4):453-60. PubMed ID: 19400764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fungal cytochrome P450 sterol 14α-demethylase (CYP51) and azole resistance in plant and human pathogens.
    Becher R; Wirsel SG
    Appl Microbiol Biotechnol; 2012 Aug; 95(4):825-40. PubMed ID: 22684327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azole antimycotics--a highway to new drugs or a dead end?
    Musiol R; Kowalczyk W
    Curr Med Chem; 2012; 19(9):1378-88. PubMed ID: 22257053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New azoles with antifungal activity: Design, synthesis, and molecular docking.
    Chai X; Zhang J; Cao Y; Zou Y; Wu Q; Zhang D; Jiang Y; Sun Q
    Bioorg Med Chem Lett; 2011 Jan; 21(2):686-9. PubMed ID: 21190856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [How do fungal infections "escape" treatment? Resistance and resistance mechanisms].
    Morschhäuser J
    Pharm Unserer Zeit; 2003; 32(2):124-8. PubMed ID: 12677965
    [No Abstract]   [Full Text] [Related]  

  • 15. Repurposing antipsychotic drugs into antifungal agents: Synergistic combinations of azoles and bromperidol derivatives in the treatment of various fungal infections.
    Holbrook SYL; Garzan A; Dennis EK; Shrestha SK; Garneau-Tsodikova S
    Eur J Med Chem; 2017 Oct; 139():12-21. PubMed ID: 28797882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in the CgPDR1 and CgERG11 genes in azole-resistant Candida glabrata clinical isolates from Slovakia.
    Berila N; Borecka S; Dzugasova V; Bojnansky J; Subik J
    Int J Antimicrob Agents; 2009 Jun; 33(6):574-8. PubMed ID: 19196495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mycoses].
    Yamazumi T; Furuta I
    Rinsho Byori; 2002 Sep; 50(9):853-9. PubMed ID: 12386962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The biology and chemistry of antifungal agents: a review.
    Kathiravan MK; Salake AB; Chothe AS; Dudhe PB; Watode RP; Mukta MS; Gadhwe S
    Bioorg Med Chem; 2012 Oct; 20(19):5678-98. PubMed ID: 22902032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RTA2, a novel gene involved in azole resistance in Candida albicans.
    Jia XM; Ma ZP; Jia Y; Gao PH; Zhang JD; Wang Y; Xu YG; Wang L; Cao YY; Cao YB; Zhang LX; Jiang YY
    Biochem Biophys Res Commun; 2008 Sep; 373(4):631-6. PubMed ID: 18601908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance of human fungal pathogens to antifungal drugs.
    Sanglard D
    Curr Opin Microbiol; 2002 Aug; 5(4):379-85. PubMed ID: 12160856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.